A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study, MS treatment in Finland has undergone a radical transformation over the past decade: diagnoses are now made more quickly, and new treatment practices align with the latest scientific evidence. The speed and extent of these changes was a surprise to the researchers.
In 2013, the average time to diagnose relapsing-remitting MS was ten months from the onset of the first symptoms. Today, the diagnosis is typically made within five months. As a result of this faster diagnostic process, treatment can also begin at an earlier stage.
Previously, treatment was typically initiated with a moderately effective medication, which…